Biotechnology Investing News Market News Technology Novavax to Acquire Praha Vaccines a.a. Author Nikita MedvedevPosted on 05/27/2020 5289 Novavax, Inc. (NASDAQ: NVAX) reported the acquisition of Praha Vaccines a.s. The all cash transaction will total approximately USD 167 Million. This acquisition also includes a biologics manufacturing facility...